Assenagon Asset Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-50,745
| Closed | -$1.25M | – | 1299 |
|
|
2024
Q3 | $1.25M | Buy |
50,745
+3,733
| +8% | +$92.2K | ﹤0.01% | 1062 |
|
|
2024
Q2 | $1.19M | Hold |
47,012
| – | – | ﹤0.01% | 1030 |
|
|
2024
Q1 | $1.19M | Sell |
47,012
-12
| -0% | -$305 | ﹤0.01% | 992 |
|
|
2023
Q4 | $1.07M | Hold |
47,024
| – | – | ﹤0.01% | 1044 |
|
|
2023
Q3 | $876K | Hold |
47,024
| – | – | ﹤0.01% | 1046 |
|
|
2023
Q2 | $1.22M | Hold |
47,024
| – | – | ﹤0.01% | 893 |
|
|
2023
Q1 | $1.35M | Sell |
47,024
-672
| -1% | -$19.3K | ﹤0.01% | 939 |
|
|
2022
Q4 | $1.41M | Sell |
47,696
-42,357
| -47% | -$1.25M | 0.01% | 902 |
|
|
2022
Q3 | $2.14M | Hold |
90,053
| – | – | 0.01% | 665 |
|
|
2022
Q2 | $2.01M | Sell |
90,053
-1,872
| -2% | -$41.8K | 0.01% | 808 |
|
|
2022
Q1 | $2.31M | Sell |
91,925
-37,578
| -29% | -$943K | 0.01% | 755 |
|
|
2021
Q4 | $4.64M | Sell |
129,503
-140,618
| -52% | -$5.04M | 0.01% | 505 |
|
|
2021
Q3 | $11.5M | Buy |
270,121
+89,100
| +49% | +$3.79M | 0.04% | 239 |
|
|
2021
Q2 | $7.84M | Buy |
181,021
+133,397
| +280% | +$5.77M | 0.03% | 356 |
|
|
2021
Q1 | $1.94M | Buy |
47,624
+6,336
| +15% | +$259K | 0.01% | 685 |
|
|
2020
Q4 | $1.87M | Sell |
41,288
-27,712
| -40% | -$1.25M | 0.01% | 505 |
|
|
2020
Q3 | $2.44M | Buy |
+69,000
| New | +$2.44M | 0.01% | 514 |
|
|
2020
Q2 | – | Sell |
-98,670
| Closed | -$2.85M | – | 1077 |
|
|
2020
Q1 | $2.85M | Buy |
98,670
+83,948
| +570% | +$2.43M | 0.02% | 266 |
|
|
2019
Q4 | $763K | Buy |
+14,722
| New | +$763K | ﹤0.01% | 568 |
|
|
2019
Q3 | – | Sell |
-12,273
| Closed | -$499K | – | 792 |
|
|
2019
Q2 | $499K | Sell |
12,273
-6,578
| -35% | -$267K | ﹤0.01% | 812 |
|
|
2019
Q1 | $570K | Sell |
18,851
-37,379
| -66% | -$1.13M | 0.01% | 753 |
|
|
2018
Q4 | $1.89M | Buy |
+56,230
| New | +$1.89M | 0.02% | 422 |
|